window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 6, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Opinion & Events

  • Advanced Therapies,Clinical & Regulatory,Opinion & Events

    NICE recommends Mirikizumab for moderately to severely active Crohn’s Disease after biologic failure

    Mirikizumab is now recommended by NICE for routine NHS use [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    How nurse practitioners and physician associates are transforming healthcare access

    As healthcare delivery evolves – especially in rural and underserved [...]

    May 5, 2026
  • Clinical & Regulatory,Opinion & Events

    Phesi CEO warns of looming Phase 3 trial failures as sponsors overlook real-world data and overcrowd sites

    New analysis reveals billions risked on overly complex trials that [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    Ciloa lands €6.5 million (£5.7 million) government backing to develop novel obesity and diabetes bio-drug

    Ciloa, a pioneer in bioengineering extracellular vesicles (EVs) for innovative [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    START launches Hope Hub to improve access to early-phase cancer trials

    START unveils the Hope Hub, a digital platform connecting patients, [...]

    May 5, 2026
  • Drug Delivery & Formulation,Manufacturing & Supply Chain,Opinion & Events

    Kindeva and Rocket Science Health partner to advance targeted intranasal delivery device

    Collaboration aims to support clinical development of platform designed to [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events

    Lisata and GATC expand partnership to develop AI-discovered treatment for opioid use disorder

    New alliance targets early 2026 for first-in-human trial of non-opioid [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Opinion & Events

    Rapid ED diagnostic linked to 39% drop in sepsis mortality, real-world study finds

    IntelliSep test from Cytovale shows potential to reshape emergency triage [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Opinion & Events

    Viz.ai gains FDA clearance for AI tool measuring subdural hemorrhage volume

    First-of-its-kind software aims to improve treatment decisions for patients with [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Opinion & Events

    Prenuvo research links alcohol and exercise to early brain and organ changes in asymptomatic adults

    Two new studies presented at the 2025 ISMRM Annual Meeting [...]

    May 5, 2026
Previous121314Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • SonoNeu exits stealth as part of $41.3M ARPA-H programme to advance sonogenetics
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
  • AC Immune amends Lilly collaboration on Tau small molecules for Alzheimer’s disease
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
  • Anixa Biosciences advances breast cancer vaccine toward Phase 2 with Cytovance manufacturing deal
    Categories: Advanced Therapies, Clinical & Regulatory, Drug Discovery & Development, Manufacturing & Supply Chain, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top